Delving into the Latest Updates on Lycorine Hydrochloride Thioester with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious Diseases

Active Indication

Hand, Foot and Mouth Disease

Inactive Indication-

Originator Organization

Shandong Dayin Oceanic Biochemicals Co. Ltd.

Active Organization

Shandong Dayin Oceanic Biochemicals Co. Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

评价注射用盐酸石蒜碱硫酯在成年健康受试者中单次和多次给药后的安全性及耐受性；评价注射用盐酸石蒜碱硫酯在成年健康受试者中单次和多次给药后的人体药代动力学特征。确定注射用盐酸石蒜碱硫酯后续研究推荐剂量，为后续临床试验给药方案和给药剂量提供依据。

[Translation]

To evaluate the safety and tolerability of Lycorine Hydrochloride Thioester for Injection after single and multiple administrations in healthy adult subjects; To evaluate the human pharmacokinetic characteristics of Lycorine Hydrochloride Thioester for Injection after single and multiple administrations in healthy adult subjects. To determine the recommended dose for subsequent studies of Lycorine Hydrochloride Thioester for Injection, and to provide a basis for the dosing regimen and dosage of subsequent clinical trials.

Start Date26 Dec 2024

Sponsor / Collaborator

Shandong Dayin Oceanic Biochemicals Co. Ltd.

100 Clinical Results associated with Lycorine Hydrochloride Thioester

Login to view more data

100 Translational Medicine associated with Lycorine Hydrochloride Thioester

Login to view more data

100 Patents (Medical) associated with Lycorine Hydrochloride Thioester

Login to view more data

100 Deals associated with Lycorine Hydrochloride Thioester

Login to view more data